Beta Lessons and practice sets are still being reviewed. If something looks wrong, check it against your textbook. Send feedback.

← Practice bank

B/B 04 · Gene regulation and steroid hormone receptors

A Reporter Assay for a Hormone-Responsive Gene

Use reporter constructs and receptor mutants to work out how a steroid hormone turns on a gene.

Passage

In eukaryotic cells, steroid hormones are lipid-soluble molecules that enter cells by passing through the plasma membrane. Inside the cell, a steroid hormone binds a specific intracellular receptor protein. The hormone–receptor complex moves to the nucleus, where it binds to short DNA sequences called hormone response elements (HREs) near the gene it controls and changes the rate of transcription. Steroid hormone receptors have separate regions, or domains, for binding the hormone (the ligand-binding domain, LBD), binding DNA (the DNA-binding domain, DBD) and interacting with other proteins that affect transcription (the activation domain, AD).

In every eukaryotic gene, general transcription factors and RNA polymerase II assemble at the core promoter, which in many genes contains a TATA box about 25 to 30 base pairs upstream of the start site. Regulatory proteins that bind to other DNA sequences, sometimes thousands of base pairs away, can increase or decrease how efficiently this machinery assembles. A regulatory sequence of this kind is useful experimentally because it can be moved, deleted or mutated independently of the gene it controls.

A researcher studies one gene that is turned on by a steroid hormone. She builds a series of reporter constructs in which the gene’s promoter, with or without its HRE, is placed in front of the coding sequence of luciferase, an enzyme whose activity is easy to measure. The constructs are introduced into cultured cells that make the normal hormone receptor, and luciferase activity is measured with and without the hormone. Activity is expressed relative to the value for the intact construct without hormone, which is set to 1. Table 1 shows the results.

A second reporter gene on a separate piece of DNA is included in every sample as a control for differences in the number of cells that take up DNA. Each luciferase value is divided by the control value before it is compared with the others, and each number is the average of three independent experiments.

Table 1. Relative luciferase activity for different reporter constructs.

Reporter constructNo hormoneWith hormone
Intact promoter and HRE120
HRE deleted11
HRE replaced by a random sequence of the same length11
HRE moved 2,000 base pairs farther upstream115
HRE inserted in the reverse orientation119
TATA box deleted from the promoter, HRE intact0.10.1

In a second experiment, she keeps the intact reporter and changes the receptor. Cells that make no receptor of their own are given a normal receptor or one of three mutant receptors. Hormone binding is tested with a labeled hormone. Binding to the HRE is tested with a gel-shift assay, which detects protein–DNA complexes in the presence of hormone. Table 2 shows the results.

Table 2. Properties of normal and mutant receptors with the intact reporter.

ReceptorBinds hormoneBinds HRE (with hormone)Luciferase activity (with hormone)
NormalYesYes20
DBD mutantYesNo1
LBD mutantNoNo1
AD mutantYesYes1

The researcher concludes that the luciferase assay can report on whether the receptor regulates the gene, and she plans to use the same assay to test other hormones, including a hormone that is a small peptide.

Questions

Question 1 of 6

Which conclusion about the HRE is best supported by the first two reporter constructs after hormone treatment?

Question 2 of 6

The HRE still works when it is moved 2,000 base pairs upstream or reversed. What does this indicate about the HRE?

Question 3 of 6

What can be concluded from the construct in which the TATA box is deleted?

Question 4 of 6

The AD mutant binds the hormone and the HRE but fails to activate the reporter. What is the most likely defect?

Question 5 of 6

Which conclusion about the receptor’s domains is best supported by the mutants in Table 2?

Question 6 of 6

The researcher plans to use the same assay with a small peptide hormone. Why is it unlikely that this peptide would work through the pathway shown in the passage?